MindWalk Holdings (HYFT) Retained Earnings (2020 - 2026)
MindWalk Holdings (HYFT) reported Retained Earnings of -$100.1 million for Q1 2026, down 12.17% year-over-year from -$113.9 million in Q1 2025, and down 2.87% quarter-over-quarter from -$97.3 million in Q4 2025.
MindWalk Holdings (HYFT) Retained Earnings (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Retained Earnings data on file, last reported at -$100.1 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$100.1 million, down 12.17% year-over-year; the trailing twelve-month figure through Jan 2026 was -$100.1 million (down 12.17% YoY), and the FY2025 annual result was -$92.5 million, down 27.2% from the prior year.
- Retained Earnings retreated to -$100.1 million in Q1 2026 per HYFT's latest filing, from -$97.3 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$33.1 million in Q1 2022 and troughed at -$100.1 million in Q1 2026.
- A 5-year average of -$67.0 million and a median of -$60.8 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2026: Retained Earnings tumbled 71.76% in 2022, then decreased 12.17% in 2026.
- A 5-year view of Retained Earnings shows it stood at -$47.6 million in 2022, then slipped by 22.76% to -$58.5 million in 2023, then tumbled by 31.65% to -$77.0 million in 2024, then declined by 26.37% to -$97.3 million in 2025, then retreated by 2.87% to -$100.1 million in 2026.
- Business Quant data shows HYFT's Retained Earnings at -$100.1 million in Q1 2026, -$97.3 million in Q4 2025, and -$95.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -838.07 Mn |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | -100.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -100.06 Mn |
| Oct 31, 2025 | -97.27 Mn |
| Jul 31, 2025 | -95.89 Mn |
| Apr 30, 2025 | -90.51 Mn |
| Jan 31, 2025 | -89.20 Mn |
| Oct 31, 2024 | -76.97 Mn |
| Jul 31, 2024 | -74.90 Mn |
| Apr 30, 2024 | -72.69 Mn |
| Jan 31, 2024 | -60.82 Mn |
| Oct 31, 2023 | -58.47 Mn |
| Jul 31, 2023 | -57.43 Mn |
| Apr 30, 2023 | -54.02 Mn |
| Jan 31, 2023 | -50.38 Mn |
| Oct 31, 2022 | -47.63 Mn |
| Jul 31, 2022 | -43.47 Mn |
| Apr 30, 2022 | -36.74 Mn |
| Jan 31, 2022 | -33.09 Mn |
| Oct 31, 2021 | -30.27 Mn |
| Jul 31, 2021 | -26.90 Mn |
| Apr 30, 2021 | -23.69 Mn |